DB
NVO

Danske Bank’s Novo Nordisk NVO Stock Holding History

Danske Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$474K – 1440
2025
Q4 		$509K Buy
+10,000
New +$511K ﹤0.01% 631
2024
Q2 		– Sell
-67,810
Closed -$8.71M – 1228
2024
Q1 		$8.71M Buy
+67,810
New +$8.07M 0.03% 447

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Danske Bank's NVO Position: Q1 2026 in Review

Danske Bank sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 10,000 shares — an estimated $474K sold.

Danske Bank first reported a position in NVO in Q1 2024 and held it in 2 quarters. The position peaked at $8.71M in Q1 2024. 1,279 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Danske Bank reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 10,000 Novo Nordisk shares in Q1 2026, an estimated $474K.
  • Danske Bank first reported a position in Novo Nordisk in Q1 2024 and held it in 2 quarters.
  • Danske Bank's Novo Nordisk position peaked at $8.71M in Q1 2024.
  • 1,279 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.